It has been shown to reduce the inflammatory response in colitis mice by inhibiting the Toll-like receptor 4 (TLR4)/Nuclear factor kappa B (NF-κB) pathway and NLR-family-pyrin-domain-containing 3 (NLRP3) inflammasome activation [59]. This evidence concerns the gene NLRP3 and colitis.